Curcumin Ag nanoconjugates for improved therapeutic effects in cancer
| dc.contributor.author | Shah, Darshini | |
| dc.contributor.author | Savaliya, Reema | |
| dc.contributor.author | Patel, Pal | |
| dc.contributor.author | Kansara, Krupa | |
| dc.contributor.author | Pandya, Alok | |
| dc.contributor.author | Dhawan, Alok | |
| dc.contributor.author | Singh, Sanjay | |
| dc.date.accessioned | 2025-05-19T05:09:47Z | |
| dc.date.available | 2025-05-19T05:09:47Z | |
| dc.date.issued | 2018-03-15 | |
| dc.description | Open Access | |
| dc.description.abstract | Curcumin has a broad spectrum of pharmacological activities, one of them is anticancer activity that is mediated through multiple mechanisms. The major disadvantage associated with the use of curcumin is its low bioavailability due to its poor aqueous solubility. Nanoformulations of curcumin provide an effective solution for this problem. In this study, we have synthesized curcumin Ag nanoconjugates and evaluated their anticancer potential. | |
| dc.identifier.citation | Shah, D., Savaliya, R., Patel, P., Kansara, K., Pandya, A., Dhawan, A., & Singh, S. (2018). Curcumin Ag nanoconjugates for improved therapeutic effects in cancer. International Journal of Nanomedicine, Volume 13, 75–77. https://doi.org/10.2147/ijn.s124696 | |
| dc.identifier.uri | https://www.dovepress.com/curcumin-ag-nanoconjugates-for-improved-therapeutic-effects-in-cancer-peer-reviewed-fulltext-article-IJN | |
| dc.identifier.uri | https://ir.ahduni.edu.in/handle/123456789/4217 | |
| dc.language.iso | en | |
| dc.publisher | Dovepress | |
| dc.title | Curcumin Ag nanoconjugates for improved therapeutic effects in cancer | |
| dc.type | Article |